JM
Jagan Mohan Rao Routh
About Jagan Mohan Rao Routh
Jagan Mohan Rao Routh has 29 years in corporate governance. Holds Managing Director and Additional Director roles. Currently with 1 company, including Dayamed Pharmaceuticals Private Limited and Oaksun Life Sciences Private Limited. Formerly with 2 companies, such as Stride Organics Private Limited. Engaged in General Business. Contributes to corporate operations.
Current companies
| Company | Designation | Appointment | Founded | Status |
|---|---|---|---|---|
Oaksun Life Sciences Private Limited
U46497TS2023PTC175256
|
Additional Director | 07 May 2025 | 2023 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Status |
|---|---|---|---|---|
Stride Organics Private Limited
U24239TG2005PTC046195
|
Whole-Time Director | 28 Jun 2005 | 2005 | Active |
Dayamed Pharmaceuticals Private Limited
U24239TG1992PTC014473
|
Managing Director | 04 Dec 1996 | 1992 | Strike Off |
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Jagan Mohan Rao Routh
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Jagan Mohan Rao Routh
Jagan Mohan Rao Routh has 29 years in corporate governance. Holds Managing Director and Additional Director roles. Currently with 1 company, including Dayamed Pharmaceuticals Private Limited and Oaksun Life Sciences Private Limited. Formerly with 2 companies, such as Stride Organics Private Limited. Engaged in General Business. Contributes to corporate operations.
Jagan Mohan Rao Routh is associated with 1 company as Managing Director and Additional Director.
Jagan Mohan Rao Routh has expertise in General Business.
Jagan Mohan Rao Routh has 29 years in corporate governance.